P

ProBio Tech Stack

Contract CDMO for viral vectors, cell therapies, and mRNA manufacturing

Biotechnology Research Pennington, New Jersey 201–500 employees Founded 2020 Privately Held

ProBio is a contract manufacturer focused on advanced therapies—viral vectors, cell and gene therapies, mRNA platforms, and antibody-drug conjugates. The tech stack is heavily industrial (SCADA, PLC, CMMS, UPS) rather than software-forward, reflecting their core competency in GMP-regulated manufacturing operations. Active projects cluster around viral vector scale-up, process technology transfer, and GMP lab buildout, while pain points center on yield optimization and translating research protocols into regulated production—typical friction points for a CDMO ramping manufacturing capacity.

Tech Stack 11 technologies

Core StackAWS SCADA PLC UPS CMMS BMS Microsoft Office Outlook Word Excel PowerPoint

What ProBio Is Building

◆Challenges

Cost control
Maintaining automation systems
Scale-up
Managing change control
Scaling up viral vector manufacturing
Translating research to gmp
Process technology transfer
Improving yield of viral vector production
Scaling up viral vector processes
Improving manufacturing capabilities

▲Active Projects

Aav/lvv purification experiments
Process technology transfer
Cgmp risk evaluation
Start up of aav/lvv lab operations
Implementation of lean 6 sigma/5s best practices
Programs for new prospective clients to increase awareness of probio’s service offerings
Territory sales strategies and tactics for products/services, new markets and new applications
Gmp qc-analytics lab setup
Engineered cell line generation
Vector performance assay development

Hiring Activity

Steady15 roles · 5 in 30d

Department

Engineering

3

Sales

3

Manufacturing

2

Ops

2

HR

1

Logistics

1

Marketing

1

Product

1

Seniority

Senior

11

Mid

2

Lead

1

Manager

1

Company intelligence

Find more companies like ProBio by tech stack, pain points and active projects

Get started free

About ProBio

ProBio is a contract development and manufacturing organization headquartered in Pennington, New Jersey, founded in 2020. They serve biotech and pharmaceutical companies seeking outsourced manufacturing for biologics, protein and mRNA vaccines, viral vectors, and cell and gene therapies. The organization spans 201–500 employees across engineering, manufacturing, operations, sales, and product functions, with active hiring in the United States, Japan, and China. Core capabilities include process development, GMP quality control, viral vector purification, engineered cell line generation, and lean manufacturing optimization.

HeadquartersPennington, New Jersey

Company Size201–500 employees

Founded2020

Hiring MarketsUnited States, Japan, China

Frequently Asked Questions

What is ProBio's manufacturing focus?

ProBio manufactures viral vectors, mRNA vaccines, cell therapies, antibody-drug conjugates, and protein-based biologics for biotech partners. They provide full CDMO services including process development, technology transfer, and GMP-regulated production.

Where is ProBio headquartered and hiring?

ProBio is based in Pennington, New Jersey and actively hiring across the United States, Japan, and China. Current open roles span engineering, manufacturing, sales, operations, and product functions.

What manufacturing challenges is ProBio working on?

Key focus areas include scaling viral vector production yield, process technology transfer from research to GMP, managing change control in regulated environments, and improving manufacturing capabilities across advanced therapy modalities.